SMPD1 and chronic myelogenous leukemia, BCR-ABL1 positive: To determine the role of ASM in EGCG-induced viable cell reduction, we evaluated the effect of the ASM inhibitor desipramine, a tricyclic antidepressant on the anti-CML effect of EGCG (Fig. 3A).